1. The first goal is to determine the site of the lesion by examining the distribution and pattern of weakness. Common patterns include proximal limb-girdle weakness, distal weakness, proximal arm/distal leg weakness, and distal arm/proximal leg weakness. 2. The second goal is to determine the cause by taking a thorough history including symptoms, temporal evolution, family history, and associated systemic features. Precipitating factors can provide clues to specific disorders. 3. The third goal is to determine if a specific treatment exists and if not, optimally manage symptoms to maximize function and quality of life. A pattern-recognition approach using historical and examination findings helps narrow the differential diagnosis.

1. Approach to myopathy

2. 1. The first goal in approaching a patient with a
suspected muscle disease is to determine the
correct site of the lesion.
1. The second goal is to determine the cause of the
myopathy.
1. The third goal is to determine whether a specific
treatment is available and if not, to optimally
manage the patient’s symptoms to maximize his or
her functional abilities and enhance quality of life.

4. Clinical
evaluatio
n
History
Examination
Investigations

5. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

6. Which negative and/or positive symptoms and
signs does the patient demonstrate?
• Negative
– Weakness
– Fatigue
– Exercise intolerance
– Muscle atrophy
• Positive
– Myalgia
– Cramps
– Contractures
– myotonia
– myoglobinuria

7. 1. Weakness:
a) Proximal lower extremities:
• difficulty climbing stairs, arising from a low chair or toilet,
or getting up from a squatted position.
b) Proximal upper extremities:
• trouble lifting objects over their head and brushing their
hair.
c) Distal upper extremities:
• difficulty opening jars, inability to turn a key in the ignition.
d) Distal lower extremities:
• tripping due to footdrop.
e) Cranial muscle weakness,
• dysarthria, dysphagia, or ptosis.

8. 2. Fatigue
• less useful negative symptom
• Nonspecific
• abnormal fatigability after exercise can result
from certain metabolic and mitochondrial
myopathies, and it is important to define the
duration and intensity of exercise that provokes
the fatigue.

9. 3. Myalgia, like fatigue, is another nonspecific
symptom
• episodic (metabolic myopathies)
• constant (inflammatory muscle disorders)
• more likely to be due to orthopedic or
rheumatological disorders

10. 4. Muscle cramp
– They are typically benign, occurring frequently in
normal individuals, and are seldom a feature of a
primary myopathy
– Cramps can occur with:
• dehydration,
• hyponatremia,
• azotemia,
• myxedema
• disorders of the nerve or motor neuron (especially
amyotrophic lateral sclerosis).

11. 5. Muscle contractures
– uncommon
– They are typically provoked by exercise in patients with
glycolytic enzyme defects.
– Contractures differ from cramps in that they usually last
longer and are electrically silent with needle EMG.

12. 6. Myotonia is the phenomenon of impaired
relaxation of muscle after forceful voluntary
contraction and most commonly involves the
hands and eyelids.
– Myotonia is due to repetitive depolarization of the muscle
membrane.
– Patients may complain of muscle stiffness or tightness
resulting in difficulty releasing their handgrip after a
handshake, unscrewing a bottle top, or opening their
eyelids if they forcefully shut their eyes.
– Myotonia classically improves with repeated exercise.

13. 6. paramyotonia congenita: ‘‘paradoxical
myotonia’’ in that symptoms are typically
worsened by exercise or repeated muscle
contractions.
• Exposure to cold results in worsening of both
myotonia and paramyotonia.

14. • Myopathies associated with muscle stiffness:
– Myotonic dystrophy
– Proxymal myotonic dystrophy
– Myotonia congenita
– Paramyotonia congenita
– Hyperkalemic periodic paralysis
– Hypothyroid myopathy

15. 8. Myoglobinuria
– uncommon manifestation of muscle disease
– caused by the excessive release of myoglobin from
muscle during periods of rapid muscle destruction
(rhabdomyolysis).
– Severe myoglobinuria can result in renal failure due to
acute tubular necrosis.
– If patients complain of exercise-induced weakness and
myalgias, they should be asked if their urine has ever
turned cola-colored or red during or after these episodes.
– Recurrent myoglobinuria is usually due to an underlying
metabolic myopathy
– isolated episodes, particularly occurring after
unaccustomed strenuous exercise, are frequently
idiopathic.

17. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

18. What is the temporal evolution?
• onset,
• duration, and
• evolution of the patient’s symptoms

19. Myopathies Presenting at Birth
• Congenital myotonic dystrophy
• Centronuclear (myotubular) myopathy
• Congenital fiber-type disproportion
• Central core disease
• Nemaline (rod) myopathy
• Congenital muscular dystrophy
• Lipid storage diseases (carnitine deficiency)
• Glycogen storage diseases (acid maltase and
phosphorylase deficiencies)

20. Myopathies Presenting in Childhood
• Muscular dystrophies
– Duchenne
– Becker
– Emery-Dreifuss
– Facioscapulohumeral
– Limb-girdle
– Congenital
• Inflammatory
myopathies
– Dermatomyositis
– Polymyositis (rarely)
• Congenital myopathies
– Nemaline
– Centronuclear
– Central core
• Lipid storage disease
(carnitine deficiency)
• Glycogen storage disease
(acid maltase deficiency)
• Mitochondrial
myopathies
• Endocrine-metabolic
disorders
– Hypokalemia
– Hypocalcemia
– Hypercalcemia

21. Myopathies Presenting in Adulthood
• Muscular dystrophies
– Limb-girdle
– Facioscapulohumeral
– Becker
– Emery-Dreifuss
• Inflammatory myopathies
– Polymyositis
– Dermatomyositis
– Inclusion body myositis
– Viral [HIV]
• Metabolic myopathies
– Acid maltase deficiency
– Lipid storage diseases
– Debrancher deficiency
– Phosphorylase b kinase deficiency
– Mitochondrial myopathies
• Endocrine myopathies
– Thyroid
– Parathyroid
– Adrenal
– Pituitary disorders
• Toxic myopathies
– Alcohol
– Corticosteroids
– Local injections of narcotics
– Colchicine
– Chloroquine
– Statins
• Myotonic dystrophy
• Distal myopathies
• Nemaline myopathy
Centronuclear myopathy

22. Evolution and duration
• episodic periods of weakness with normal
strength interictally
– (periodic paralysis, metabolic myopathies due to
certain glycolytic pathway disorders).
• constant weakness

23. Constant weakness
• acute or subacute progression
– inflammatory myopathies (dermatomyositis and
polymyositis);
• chronic slow progression over years
– most muscular dystrophies
– IBM
• nonprogressive weakness with little change
over decades
– congenital myopathies

24. Monophasic or relapsing
• polymyositis can occasionally have an acute
monophasic course with complete resolution
of strength within weeks or months.
• Patients with periodic paralysis or metabolic
myopathies can have recurrent attacks of
weakness over many years,
• a patient with acute rhabdomyolysis due to
cocaine may have a single episode.

25. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

26. Precipitating factors
• illegal drug or prescription medication use that might produce
a myopathy.
• weakness, pain, and/or myoglobinuria provoked by exercise
– a glycolytic pathway defect.
• Episodes of weakness with a fever
– carnitine palmityl transferase deficiency.
• Periodic paralysis is characteristically provoked by exercise or
ingestion of a carbohydrate meal followed by a period of rest.
• Patients with paramyotonia congenita frequently report that
cold exposure may precipitate their symptoms of muscle
stiffness.

27. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

28. Are associated systemic symptoms or signs present?
Cardiac disease
• Arrhythmias
– Kearns-Sayre syndrome
– Andersen’s syndrome
– Polymyositis
– Muscular dystrophies
• Myotonic
• Limb-girdle 1B, 2C-2F, 2G
• Emery-Dreifuss"
• Congestive Heart Failure
– Muscular dystrophies
• Duchenne
• Becker
• Emery-Dreifuss
• Myotonic
• Limb-girdle 1B, 2C-2F, 2G
– Nemaline myopathy
– Acid maltase deficiency
– Carnitine deficiency
– Polymyositis

29. Respiratory Insufficiency
• Muscular Dystrophies
– Duchenne
– Becker
– Emery-Dreifuss
– Limb-girdle
– Myotonic
– Congenital
• Metabolic Myopathies
– Acid maltase deficiency
– Carnitine deficiency
• Mitochondrial
Myopathies
• Congenital Myopathies
– Nemaline
– Centronuclear
• Inflammatory
Myopathies
– Polymyositis

30. Hepatomegaly
• may be seen in myopathies associated with
deficiencies in acid maltase, debranching
enzyme,
• infectious disease.
• mitochondrial disorder.

31. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

32. Family history
• A thorough family history is clearly of great
importance in making a correct diagnosis.
• Questions regarding family members’ use of
canes or wheelchairs, skeletal deformities, or
functional limitations are usually more
informative than questions such as, ‘‘Does any
member of your family have a muscle
disease?’’

33. Diagnosis of Myopathy Based on Pattern of
Inheritance
• X-Linked
– Duchenne
– Becker
– Emery-Dreifuss
• Autosomal Dominant
– Facioscapulohumeral
– Limb-girdle
– Oculopharyngeal
muscular dystrophy
– Myotonic dystrophy
– Periodic paralysis
– Paramyotonia congenita
– Thomsen disease
– Central core myopathy"
• Autosomal Recessive
– Limb-girdle
– Metabolic myopathies
– Becker myotonia
• Maternal Transmission
– Mitochondrial myopathies

34. History
Which negative and/or positive
symptoms and signs does the
patient demonstrate?
What is the distribution of
weakness?
Family history What is the temporal
evolution?
Are there precipitating
factors that trigger episodic
weakness or myotonia?
Are associated systemic
symptoms or signs present?

35. What is the distribution of weakness?
• it is important to know which muscles to test
and how to grade their power

36. – Atrophy
• selective atrophy of the
quadriceps and forearm
flexor muscles is highly
suggestive of inclusion
body myositis.
• Distal myopathies may have
profound atrophy of the
anterior or posterior lower
extremity compartments.
• (LGMD 2G in 50% of pt)
– Hypertrophy
• LGMD2C–2F, LGMD2I,
(LGMD 2G in 50% of pt)
• myotonia congenita
• amyloidosis,
• sarcoidosis, and
• hypothyroid myopath
– Pseudohypertrophy
• Duchenne and Becker
dystrophy
– Fasciculation- MND or
neuropathy
– Scapular wining
• FSHD.
• LGMD1B (laminopathy),
LGMD2A (calpainopathy),
LGMD2C–2F
(sarcoglycanopathies).
Inspection

38. PATTERN-
RECOGNITION
APPROACH TO
MYOPATHIC
DISORDERS
Proximal Limb-Girdle Weakness
Prominent Neck Extensor
Weakness
Distal Weakness
Ptosis With or Without
Ophthalmoplegia
Proximal Arm/Distal Leg
Weakness
Distal
Arm/ProximalLeg
Weakness

40. Pattern 1: Proximal Limb-Girdle Weakness
• The most common pattern of muscle weakness in myopathies
• symmetrical weakness affecting predominantly the proximal
muscles of the legs and arms
• The distal muscles are usually involved, but to a much lesser
extent.
• Neck extensor and flexor muscles are also frequently affected.
• This pattern of weakness is seen in most hereditary and
acquired myopathies and therefore is the least specific in ar-
riving at a particular diagnosis

41. Pattern 2: Distal Weakness
• This pattern of weakness predominantly
involves the distal muscles of the upper or
lower extremities (anterior or posterior
compartment muscle groups)
• The involvement is usually, although not
invariably, symmetrical.
• more commonly a feature of neuropathies

42. Myopathies Characterized by Predominantly Distal
Weakness
• Distal Myopathies
– Late adult-onset distalmyopathy type 1
(Welander)
– Late adult-onset distal myopathy type 2
(Markesbery/Udd)
– Early adult-onset distal myopathy type 1
(Nonaka)
– Early adult-onset distal myopathy type 2
(Miyoshi)
– Early adult-onset distal myopathy type 3
(Laing)
– Desmin myopathy
– Childhood-onset distal myopathy"
• Myotonic Dystrophy
• FSHD*"
• Scapuloperoneal Myopathy*"
• OPMD
• Emery-Dreifuss Humeroperoneal
Dystrophy*"
• Inflammatory Myopathies
• Inclusion Body Myositis
• Metabolic Myopathies
– Debrancher deficiency
– Acid-maltase deficiency*"
• Congenital Myopathies
– Nemaline myopathy*
– Central core myopathy*
– Centronuclear myopathy
*" Scapuloperoneal pattern can occur

43. Pattern 3: Proximal Arm/Distal Leg Weakness
• This pattern of weakness affects the periscapular muscles of
the proximal arm and the anterior compartment muscles of
the distal lower extremity (scapuloperoneal distribution)
• The scapular muscle weakness is usually characterized by
scapular winging.
• Weakness can be very asymmetrical.

44. Myopathies with proximal arm/distal leg
involvement (scapuloperoneal)
• Scapuloperoneal dystrophy,
• Emery-Dreifuss dystrophy,
• LGMD1B, LGMD2A, LGMD2C–2F,
• Congenital myopathies,
– Nemaline myopathy
– Central core myopathy
• acid maltase deficiency.
• When this pattern is associated with facial
weakness->(FSHD)

45. Pattern 4: Distal Arm/ProximalLeg Weakness
• This pattern is associated with distal arm weakness involving
the distal forearm muscles (wrist and finger flexors) and
proximal leg weakness involving the knee extensors
(quadriceps).
• The facial muscles are usually spared.
• Involvement of other muscles is extremely variable.
• The weakness is often asymmetrical between the two sides,
which is uncommon in most myopathies.
• This pattern is essentially pathognomonic for inclusion body
myositis (IBM).
• This pattern may also represent an uncommon presentation
of myotonic dystropy; however, unlike IBM, muscle weakness
is usually symmetrical

46. Pattern 5: Ptosis With or Without
Ophthalmoplegia
• usually, although not always, occurs without
symptoms of diplopia.
• Facial weakness is not uncommon,
• extremity weakness is extremely variable,
depending on the diagnosis.

47. • The combination of ptosis, ophthalmoplegia (without
diplopia), and dysphagia should suggest the
diagnosis of oculopharyngeal dystrophy, especially if
the onset is in middle age or later.
• Ptosis and ophthalmoplegia without prominent
pharyngeal involvement is a hallmark of many of the
mitochondrial myopathies.
• Ptosis and facial weakness without ophthalmoplegia
is a common feature of myotonic dystrophy.

48. Myopathies With Ptosis or Ophthalmoplegia
Ptosis Without Ophthalmoplegia
• Myotonic dystrophy
• Congenital myopathies
– Centronuclear myopathy
– Nemaline myopathy
– Central core myopathy
• Desmin (myofibrillary)
myopathy
Ptosis With Ophthalmoplegia
• Oculopharyngeal muscular
dystrophy
• Oculopharyngodistal
myopathy
• Chronic progressive external
ophthalmoplegia
(mitochondrial myopathy)
• Neuromuscular junction
disease (myasthenia gravis,
Lambert-Eaton, botulism)

49. Pattern 6: Prominent Neck Extensor Weakness
• ‘‘dropped head syndrome’’
• Involvement of the neck flexors is variable.
• Isolated neck extension weakness represents a
distinct muscle disorder called isolated neck
extensor myopathy.
• Prominent neck extensor weakness:
– amyotrophic lateral sclerosis and
– myasthenia gravis.

50. Myopathies With Prominent Neck Extensor
Weakness
• Isolated neck extensor myopathy"
• Polymyositis "
• Dermatomyositis "
• Inclusion body myositis "
• Carnitine deficiency "
• Facioscapulohumeral dystrophy "
• Myotonic dystrophy "
• Congenital myopathy "
• Hyperparathyroidism

51. Clinical
evaluation
History
Examination
Investigations

52. Investigations
Genetics
Muscle
Biopsy
NCS/EM
G
Lab ( CK)

53. Creatine Kinase
• The CK is elevated in the majority of myopathies but may be
normal in slowly progressive myopathies.
• Duchenne dystrophy, the CK level is invariably at least 10
times (and often up to 100 times) normal.
• CK may also be markedly elevated:
– LGMD1C (caveolinopathy),
– LGMD2A (calpainopathy), and
– LGMD2B (dysferlinopathy),
• The CK level may not be elevated in
– corticosteroid administration,
– collagen diseases,
– alcoholism
– hyperthyroidism
– profound muscle wasting

54. Differential Diagnosis of Creatine Kinase
Elevation
• Myopathies
– Muscular dystrophies
– Congenital myopathies
– Metabolic myopathies
– Inflammatory myopathies
– Drug/toxin-induced
– Carrier state (dystrophinopathies)
• Channelopathies
• Motor Neuron Diseases
– ALS
– SMA
– Postpolio syndrome
• Neuropathies
– GBS
– CIDP
• Viral Illness
• Medications
• Hypothyroidism/ Hypoparathyroidism
• SurgeryTrauma (electromyography
studies, intramuscular or
subcutaneous injections)
• Strenuous Exercise
• Increased Muscle Mass
• Race
• Sex
• ‘‘Idiopathic HyperCKemia’’

55. Electrophysiological Studies
• Confirm localization
• can be a guide as to which muscle to
biopsy.
• r/o neuropathy, NMG disease, MND.
• NCS are typically normal in patients
with myopathy.
• Needle EMG examination: motor
units
– Brief duration,
– small-amplitude
– Early recruitment

56. Muscle biopsy
• Selection of the appropriate muscle to biopsy is critical.
• Muscles that are severely weak (MRC grade 3 or less) should
not be biopsied, since the results are likely to show only
evidence of end stage muscle disease
• muscles that have recently been studied by needle EMG
should be avoided because of the possibility of artifacts
created by needle insertion.

57. • Biopsies should generally be taken from muscles that
demonstrate MRC grade 4 strength.
• The muscle of choice:
– biceps.
– vastus lateralis.
• The gastrocnemius should be avoided, since its
tendon insertion extends throughout the muscle and
inadvertent sampling of a myotendinous junction
may cause difficulty with interpretation.

58. • Typical myopathic abnormalities include:
– central nuclei,
– both small and large hypertrophic round fibers,
– split fibers, and
– degenerating and regenerating fibers.
– Chronic myopathies frequently show evidence of
increased connective tissue and fat.

59. Inflammatory myopathies
• characterized by:
– the presence of mononuclear inflammatory cells
in the endomysial and perimysial connective
tissue between fibers and occasionally around
blood vessels ( perivascular)

60. Dermatomyositis
• …….In addition,
• perifascicular atrophy,
characterized by atrophy of
fibers located on the periphery
of a muscle fascicle, is a
common finding.
• Inflammatory cell invasion of
nonnecrotic fibers is not
prominent.
• deposition of the C5b-9 or
membrane attack complex on
or around small blood vessels

61. polymyositis
• variability in fiber size,
• scattered necrotic and
regenerating fibers,
• endomysial inflammation
with invasion of non-
necrotic muscle fibers

62. IBM
• endomysial inflammation with invasion of
non-necrotic muscle fibers
• small groups of atrophic fibers,
• eosinophilic cytoplasmic inclusions, and
muscle fibers with one or more rimmed
vacuoles lined with granular material
• Amyloid deposition is evident on Congo red
staining.
• TDP-43 positive
• Ubiquitin positive
• Electron microscopy demonstrates 15-nm to
21-nm cytoplasmic and intranuclear
tubulofilaments

64. Mitochondrial disorder
• The typical muscle
histopathology is “ragged red’’
fibers
• subsarcolemmal accumulation
of abnormal mitochondria
stains red.
• best seen with modified–
Gomori trichrome stain

65. • Type 1 fibers (slow-twitch, fatigue-resistant,
oxidative metabolism) stain lightly at alkaline
and darkly at acidic pH levels.
• Type 2 fibers (fast- twitch, fatigue-prone,
glycolytic metabolism) stain darkly at alkaline
and lightly at acidic pH levels.
• Normally, a random distribution of the two
fiber types occurs, and generally twice as
many type 2 as type 1 fibers are identified.

67. • W
• Increased variability in muscle fiber size
• degeneration, regeneration, isolated ‘‘opaque’’
hypertrophic fibers, and significant replacement of
muscle by fat and connective tissue.
• Central nuclei are present in 2% to 4% of the fibers.
• Type 1 fiber predominance is seen in most patients.
• Inflammatory cell infiltrates in the perimysium,
endomysium, and perivascular spaces and consist
mostly of mononuclear cells, especially
macrophages.
• endomysial and perimysial fibrosis with disease
progression

70. Nemaline myopathy
• Type I fiber predominance and atrophy
• Marked disproportion in fiber size, with
uniformly small type I fibers and normal
to large type II fibers
• Sarcoplasmic rods (nemaline bodies)
– Short, granular-appearing
– Subsarcolemmal and perinuclear
localization in type I fibers (especially
large rods)
– Composed of α-actinin, actin, and
other Z diskproteins, and appear to
arise from, are attached to,and
thicken the Z disk (small rods)
• Intranuclear rods

71. • Myotubular (centronuclear)
Myopathy
– Is called “centronuclear” because of
predominance of small type I fibers
with central nucleib.
– Type I fiber predominance (often
small, atrophied)
– Central pallor noted on ATPase
stainingd.
– Radial distribution of sarcoplasmic
strands apparent on NADH
reactione.
– Interstitial connective tissue:
normal or mildly increased

72. • Central Core Disease
• Type I fiber predominance
• Central cores
– Single, well-circumscribed regions
– Selectively involve type I fibers
– Deficient in mitochondria and sarcoplasmic reticulum as well as oxidative
enzymes and phosphorylase activity (detected best on sections with oxidative
enzyme immunohistochemistry ,as poorly stained central demarcated areas)
– Extend entire length of muscle fiber
• Increased endomysial connective tissue.
• Often, increased number of internal nuclei

74. Molecular Genetic Studies
• Disorders With Commercially Available Molecular Genetic
Studies Performed With Peripheral Blood Samples
– Duchenne and Becker muscular dystrophies ”
– FSHD
– MD (types 1 and 2) "
– OPMD
– LGMD1B, 2A, 2C–2F, and 2I "
– Congenital muscular dystrophy (FKRP, FCMD, MEB, and POMT1
mutations) "
– Nonaka myopathy/inclusion body myopathy type 2 "
– Nemaline myopathy (ACTA1 mutations) "
– Myotubular myopathy (MTM1 mutations) "
– MERRF
– MELAS

76. Case 1
• A 51-year-old man without significant past
medical
• Slowly progressive muscle weakness for the
past 7 years.
• His symptoms initially began with difficulty
walking down stairs because his left knee
would ‘‘give out.’’
• He currently has difficulty arising from a chair
and grasping objects with his right hand.

78. • Current examination reveals intact cranial nerves,
sensation, and muscle stretch reflexes.
• Motor examination in the right upper extremity
shows MRC grade 5 shoulder abduction, grade 5
elbow flexion/extension, grade 4 wrist flexion,
grade 5 wrist extension, and grade 3 finger
flexion.
• Strength in the left upper extremity is normal
except for grade 4+ finger flexion.
• In the left lower extremity, the patient exhibits
grade 4+ hip flexion, grade 3+ knee extension,
and grade 4+ ankle dorsiflexion.
• In the right lower extremity, strength is normal
except for grade 4+ knee extension.

79. • The chronic onset, asymmetrical distribution
of weakness, and selective involvement of
wrist/finger flexion and knee extension
• CK= 500
• EMG= myopathy
• Muscle biopsy

80. IBM

81. Case 2
• Describe and give DDx.

82. FSHD
• normal deltoids
• biceps, triceps commonly weak, forearm
muscles are less involved resulting in a popeye-
like appearance
• wrist flexors stronger than wrist extensors
• hip flexors and quadriceps are weaker, plantar
flexors are preserved, ankle dorsiflexion is
weak and foot drop may be the presenting
symptom
• Scapular winging may be very asymmetric
(misdiagnosed as long thoracic nerve of Bell
palsy)

83. • Thanks!